نتائج البحث - "Fabiënne A. R. M. Warmerdam"

1

دورية أكاديمية

A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report

المؤلفون: Arie J. Verschoor, Fabiënne A. R. M. Warmerdam, Tjalling Bosse, Judith V. M. G. Bovée, Hans Gelderblom

المصدر: BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)

مصطلحات موضوعية: Pazopanib, Endometrial stromal sarcoma, Liver function, Adverse events, Response, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-018-3999-0; https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/10d1511c41524bb0a0bf64a8538f0a19

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

Full Text Finder

2

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

المساهمون: Pathology, CCA - Imaging and biomarkers, Amsterdam Gastroenterology Endocrinology Metabolism, Internal medicine, Medical oncology, Surgery, Oncology, AGEM - Re-generation and cancer of the digestive system

المصدر: Nature Communications, 11(1):525. Nature Publishing Group UK
Nature Communications, 11
Nature Communications, 11(1). NATURE PUBLISHING GROUP
Nature Communications, 11, 1
Leal, A, van Grieken, N C T, Palsgrove, D N, Phallen, J, Medina, J E, Hruban, C, Broeckaert, M A M, Anagnostou, V, Adleff, V, Bruhm, D C, Canzoniero, J V, Fiksel, J, Nordsmark, M, Warmerdam, F A R M, Verheul, H M W, van Spronsen, D J, Beerepoot, L V, Geenen, M M, Portielje, J E A, Jansen, E P M, van Sandick, J, Meershoek-Klein Kranenbarg, E, van Laarhoven, H W M, van der Peet, D L, van de Velde, C J H, Verheij, M, Fijneman, R, Scharpf, R B, Meijer, G A, Cats, A & Velculescu, V E 2020, ' White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer ', Nature Communications, vol. 11, no. 1, 525 . https://doi.org/10.1038/s41467-020-14310-3
Nature Communications
Nature communications, 11(1):525. Nature Publishing Group
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, SURGERY, General Physics and Astronomy, Disease, law.invention, Prognostic markers, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Randomized controlled trial, law, Leukocytes, lcsh:Science, Randomized Controlled Trials as Topic, Multidisciplinary, PLASMA, CLONAL HEMATOPOIESIS, DNA, Neoplasm, CHEMOTHERAPY, Prognosis, 3. Good health, Haematopoiesis, medicine.anatomical_structure, Cell-free fetal DNA, 030220 oncology & carcinogenesis, SURVIVAL, Cell-Free Nucleic Acids, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.medical_specialty, CARCINOMA, Science, Proof of Concept Study, Article, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, LUNG-CANCER, All institutes and research themes of the Radboud University Medical Center, Stomach Neoplasms, Internal medicine, White blood cell, REGRESSION, medicine, Humans, Survival analysis, business.industry, CIRCULATING TUMOR DNA, Cancer, Sequence Analysis, DNA, General Chemistry, Perioperative, medicine.disease, Survival Analysis, Hematopoiesis, 030104 developmental biology, lcsh:Q, Neoplasm Recurrence, Local, Gastric cancer, business, ACQUIRED-RESISTANCE

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b47eb72ae34b19261aae2b68d7be87a
https://doi.org/10.1038/s41467-020-14310-3

Find this article in full text from ProQuest

3

Abstract 354: Mucinous phenotype is associated with response to neoadjuvant chemotherapy in microsatellite instable resectable gastric cancer

المصدر: Cancer Research. 81:354-354

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Cancer, Microsatellite instability, Perioperative, medicine.disease, Gastroenterology, Phenotype, digestive system diseases, Oncology, Internal medicine, medicine, Immunohistochemistry, Microsatellite, business, Chemoradiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a00c9e540e4015b7fdf7f4a23b02ee61
https://doi.org/10.1158/1538-7445.am2021-354

4

Circulating tumor DNA dynamics in resectable gastric cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Cancer, medicine.disease, Unmet needs, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Circulating tumor DNA, 030220 oncology & carcinogenesis, Internal medicine, Perioperative chemotherapy, Medicine, sense organs, business, Predictive biomarker

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968555c273d24cb03357e447595f7e0a
https://hdl.handle.net/1887/122924

5

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

المؤلفون: Suzanne S. Gisbertz, Peter D. Siersema, Erik J. Schoon, Nadia Haj Mohammad, Liekele E. Oostenbrug, Lucas Goense, Maarten C.C.M. Hulshof, Nanda C. Krak, Michael Doukas, Caroline M. van Rij, H.J.T. Rutten, Mjr Janssen, Richard van Hillegersberg, Manon C.W. Spaander, Mark J. Roef, Mark I. van Berge Henegouwen, Sjoerd M. Lagarde, Joel Shapiro, Meindert N. Sosef, Frank P. Vleggaar, Sybren L. Meijer, Maurice J.C. van der Sangen, Roelf Valkema, Chella Van Der Post, Kausilia K. Krishnadath, Camiel Rosman, Ewout W. Steyerberg, G. Johan A. Offerhaus, Wendy M. J. Schreurs, Geert-Jan Creemers, Sandra A Radema, Wouter L. Curvers, Katharina Biermann, Hanneke W. M. van Laarhoven, Jaques Jghm Bergman, Jeroen Buijsen, Bas P. L. Wijnhoven, Grard A. P. Nieuwenhuijzen, Fabiënne A. R. M. Warmerdam, Jan-Werner Poley, Ate van der Gaast, Monique G.G. Hobbelink, Robert G. Riedl, J. Jan B. van Lanschot, Bo Jan Noordman

المساهمون: Surgery, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Radiotherapy, Gastroenterology and Hepatology, Oncology, Pathology, Gastroenterology & Hepatology, Radiology & Nuclear Medicine, Medical Oncology, Public Health

المصدر: Lancet Oncology, 19, 965-974
lancet oncology, 19(7), 965-974. Lancet Publishing Group
Lancet Oncology, 19(7), 965-974. Lancet Publishing Group
Lancet Oncology, 19, 7, pp. 965-974
The Lancet Oncology, 19(7), 965-974

مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Biopsy, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], Clinical endpoint, Carcinoma, medicine, Prospective cohort study, Survival rate, Neoadjuvant therapy, medicine.diagnostic_test, business.industry, medicine.disease, Radiation therapy, Oncology, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, Adenocarcinoma, 030211 gastroenterology & hepatology, Radiology, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3489058872d10b61a0e1fa23f8ba2a
https://doi.org/10.1016/S1470-2045(18)30201-8

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

6

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

المؤلفون: Andrzej Piwowar, Fransje Aa Valster, Jeffrey P.B.M. Braak, Marije Ie Appels, Frits van Coevorden, Niels H Nielsen, Johanna E.A. Portielje, Jeroen Buijsen, Petra Flygare, Marije Slingerland, Nicole C.T. van Grieken, Jetske M. Meerum Terwogt, Maartje Los, Mattias Elmlund, Henk Boot, Rob L. H. Jansen, Johanna W. van Sandick, A. Haringhuizen, Johannes J. Bonenkamp, Harm van Tinteren, Edwin P.M. Jansen, Henk H. Hartgrink, Jaap De Boer, Anouk K. Trip, Ge Jpm Jonkers, Marie Louise Jespersen, Cecillia Lagerbäck, Per Edlund, Marco B Polée, Mats Perman, J (Hans)-Martin Mb Otten, Marjan A Van Dijk, Danny Houtsma, A (Bert) Jan Ten Tije, Arnold Baars, Olaf Jl Loosveld, Maud M. Geenen, Maarten C.C.M. Hulshof, Gerrit-Jan Veldhuis, Erik W Muller, Geert-Jan Creemers, Annelie Je Vulink, Quirijn A. J. Eijsbouts, Annerie Slot, Diane Grootenboers, Hein Putter, Ellen M Hendriksen, Maurice J.C. van der Sangen, Fabiënne A. R. M. Warmerdam, Tom Rozema, HA A. Maurits Swellengrebel, Henk K Van Halteren, Ate van der Gaast, Marcel Verheij, Richard Van Hilligersberg, Helene Hörberg, Pehr Lind, Annemieke Cats, Cornelis J.H. van de Velde, Jitty M Smit, Alex L. T. Imholz, Donald L. van der Peet, Aart Van Bochove, Henk M.W. Verheul, Adelheid Me Van der Torren-Conze, Frans L. G. Erdkamp, Dick Johan van Spronsen, Mark I. van Berge Henegouwen, Ernst Jan Spillenaar Bilgen, Johanna Mgh Van Riel, Marien O Den Boer, Hanneke W. M. van Laarhoven, Marjolein Em Rentinck, Ron C Rietbroek, Bengt Johansson, David Borg, Anders Johnsson, Aart Beeker, Reinoud J. B. Blaisse, Miriam Koopman, Daan Ten Bokkel Huinink, Karen J. Neelis, Elma Meershoek-Klein Kranenbarg, Djamila Boerma, Heleen M. Ceha, Bea C Tanis, Marie-Cecile Jc Legdeur, O Aart Van Dobbenburgh, Steven Vanhoutvin, Sjoerd Hovenga, Karolina Sikorska, Pètra M Braam, H Pieter van den Berg, Huub van der Mijle, Marianne Nordsmark, Bengt Glimelius

المساهمون: Oncology, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Surgery, Radiotherapy, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde, Pathology, CCA - Cancer Treatment and quality of life, VU University medical center, Radiation Oncology, AGEM - Digestive immunity, Medical oncology, Plastic, Reconstructive and Hand Surgery

المصدر: lancet oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group

مصطلحات موضوعية: Male, 0301 basic medicine, Time Factors, medicine.medical_treatment, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, I-II, education.field_of_study, Middle Aged, Neoadjuvant Therapy, Progression-Free Survival, Europe, GASTROESOPHAGEAL JUNCTION, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Epirubicin, medicine.drug, medicine.medical_specialty, Population, Adenocarcinoma, Sudden death, Medication Adherence, CISPLATIN, 03 medical and health sciences, Gastrectomy, Stomach Neoplasms, medicine, DOSE-ESCALATION, Humans, Progression-free survival, CAPECITABINE CHEMOTHERAPY, education, Aged, Neoplasm Staging, Chemotherapy, III TRIAL, Performance status, business.industry, PERIOPERATIVE CHEMOTHERAPY, Chemoradiotherapy, Adjuvant, Surgery, Oxaliplatin, 030104 developmental biology, NODAL DISSECTION, Quality of Life, Lymph Node Excision, Dose Fractionation, Radiation, business, POSTOPERATIVE CHEMORADIOTHERAPY, Chemoradiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21019f3b155741c37a17771cdb957cb
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

7

Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation

المؤلفون: Jules L.L.M. Coenen, Hans Gelderblom, Andries M. Bergman, Theo van Voorthuizen, Inge M. van Oort, Maartje Los, Emile D. Kerver, Maureen J.B. Aarts, John B. A. G. Haanen, Hendrik van den Berg, Sushil K Badrising, Paul Hamberg, Fabiënne A. R. M. Warmerdam, Igle J. de Jong, Suzan Vrijaldenhoven, Alfons J.M. van den Eertwegh, Vincent van der Noort

المصدر: Prostate

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6e99d3e10bea083d3b22ff9aef2637f6
https://doi.org/10.1002/pros.23094

View record at Wiley

8

A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

المؤلفون: Maaike Berbee, Frans L. G. Erdkamp, Philippe Lambin, Marius Nap, Wouter van Elmpt, Wendy M. J. Schreurs, Ruben T. H. M. Larue, Lien Van De Voorde, Kranthi M. Panth, Meindert N. Sosef, Ann Claessens, S. Peeters, Fabiënne A. R. M. Warmerdam, Ludwig Dubois

المساهمون: Promovendi ODB, Radiotherapie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Radiotherapie OC (9), Ondersteunend personeel ODB, Afdeling Onderwijs FHML

المصدر: BMC Cancer, 16:644. BioMed Central Ltd
BMC Cancer

مصطلحات موضوعية: Male, Oncology, Cancer Research, Esophageal Neoplasms, medicine.medical_treatment, 030218 nuclear medicine & medical imaging, Evofosfamide, Study Protocol, chemistry.chemical_compound, 0302 clinical medicine, Surgical oncology, Medicine, Dose limiting toxicity, Standard treatment, Oesophageal cancer, Cell Hypoxia, 3. Good health, Neoadjuvant chemoradiotherapy, Treatment Outcome, Nitroimidazoles, 030220 oncology & carcinogenesis, Female, Phosphoramide Mustards, medicine.symptom, medicine.medical_specialty, Adenocarcinoma, 03 medical and health sciences, Internal medicine, Preoperative Care, Genetics, Humans, Window-of-opportunity trial, Hypoxia imaging, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Chemoradiotherapy, Adjuvant, Hypoxia (medical), Survival Analysis, Surgery, Oesophagectomy, Esophagectomy, Clinical trial, chemistry, Positron-Emission Tomography, business, Chemoradiotherapy, Blood sampling